Seeing First: Introducing the Resource Report at <i>Cancer Immunology Research</i>

Douglas Adams once wrote, “See first, think later, then test. But always see first. Otherwise you will only see what you were expecting.” (So Long, and Thanks for All the Fish, Hitchhiker’s Guide to the Galaxy Series Book #4, 1984, spoken by Wonko the Sane). Indeed, the scientific method begins with observation, and in immunology and cancer immunology, many of our most important insights have arisen not from a tidy hypothesis, but from careful, system-level observation that revealed patterns worth pursuing. In this spirit, Cancer Immunology Research (CIR) is launching “Resource Reports” articles whose central contribution is an especially useful dataset, technology, atlas, or curated compendium that the field can build upon. In this issue, our first Resource Report, by Sidiropoulos and colleagues (1), exemplifies this promise. It offers a carefully profiled view of tertiary lymphoid structure (TLS) maturation after neoadjuvant immunotherapy in pancreatic ductal adenocarcinoma and provides a multimodal dataset that can be explored from many new angles.What will CIR be looking for and what does it mean for an article to function as a resource rather than a conventional hypothesis-driven study? The primary value is resourcefulness through the creation, assembly, and open sharing of data, atlases, tools, or benchmarks that unlock future analyses and hypothesis generation. However, these articles should also show utility through a scientifically rigorous demonstration that yields new cancer immunology insights.CIR’s move complements other American Association for Cancer Research efforts to provide venues for durable community resources. Molecular Cancer Research, for example, recently launched Cancer Research Resources to showcase biological and computational models and sophisticated atlases, highlighting artificial intelligence and spatial technologies as drivers of discovery and hypothesis generation. Similarly, Cancer Research created a dedicated series for computational and data science work, noting that the pace and scale of data now demand new publishing structures that bridge communities and speed translation. CIR’s Resource Reports serve that same mission for cancer immunology by publishing rigorously vetted, immediately reusable assets that empower the community, especially when the data or methods derive from challenging sources such as neoadjuvant trial specimens, spatial multiomics, longitudinal T-cell receptor tracking, or rare indications.Resource Reports will also align with evolving norms for transparency. The NIH’s Data Management and Sharing Policy requires plans that enable access and reuse of scientific data. Along these lines, clear deposition, machine-readable metadata, and usable code also make it feasible for others to reproduce and extend findings quickly. This is also increasingly important as artificial intelligence methods are developed to better leverage existing data.The inaugural Resource Report by Sidiropoulos and colleagues (1) provides a strong example of this model. The authors generated a spatial multiomics atlas of pancreatic ductal adenocarcinoma tumors and adjacent lymph nodes after neoadjuvant immunotherapy. Their work integrates machine learning analysis of hematoxylin and eosin images, imaging mass cytometry, and spatial transcriptomics to define TLS niches, their maturation states, and the surrounding stromal context. The dataset links TLS-associated gene programs with survival and highlights features of local immune activity, including B-cell maturation, IgG production, and stromal remodeling.This type of resource enables many directions of follow-up. Investigators might train and validate image-based classifiers of TLS maturity for application across cohorts, test whether TLS-linked transcriptional programs predict immunotherapy response in other datasets, or probe specific effector signatures identified by their spatial analysis. The transcriptomic data might also allow extraction of B-cell receptor or T-cell receptor sequences from TLS, supporting clonal lineage reconstruction and antibody discovery. In short, the report offers a versatile foundation for both mechanistic studies and translational applications.Looking ahead, the second Resource Report, by Brummel and colleagues (2), will appear in the December issue of the journal. We anticipate that this and other future Resource Reports will highlight equally impactful contributions across the full scope of the cancer immunology field. By sharing difficult-to-obtain datasets, innovative platforms, and innovative analytic frameworks, authors can ensure that their observations become foundations for many discoveries to come.E.W. Newell reports personal fees from ImmunoScape, Neogene Therapeutics, and NanoString outside the submitted work.